Wegovy Weight Loss Stock Image - Search News

News

Eli Lilly Vows to Make Weight-Loss Pill in U.S.

Investopedia on MSN · 1d

Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results

Shares of Eli Lilly jumped 12% in premarket trading Thursday after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that "demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.

The New York Times · 21h

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

New York Post on MSN · 1d

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.

6h

Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

4don MSN

Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results